Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
Multiple myeloma (MM) is a clonal plasma cell proliferative malignancy characterized by a debilitating bone disease. Osteolytic destruction, a hallmark of MM, is driven by increased osteoclast number and exacerbated bone resorption, primarily fueled by the excessive production of RANKL, the master...
Saved in:
| Main Authors: | Aric Anloague, Hayley M. Sabol, Japneet Kaur, Sharmin Khan, Cody Ashby, Carolina Schinke, C. Lowry Barnes, Farah Alturkmani, Elena Ambrogini, Michael Tveden Gundesen, Thomas Lund, Anne Kristine Amstrup, Thomas Levin Andersen, Marta Diaz-delCastillo, G. David Roodman, Teresita Bellido, Jesus Delgado-Calle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-11-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin II Promotes Osteocyte RANKL Expression via AT1R Activation
by: Jiayi Ren, et al.
Published: (2025-02-01) -
Treatment of myeloma bone disease: When, how often, and for how long?
by: Michael Tveden Gundesen, et al.
Published: (2025-06-01) -
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
by: Hayley M. Sabol, et al.
Published: (2025-08-01) -
Control of bone mass and remodeling by PTH receptor signaling in osteocytes.
by: Charles A O'Brien, et al.
Published: (2008-08-01) -
Palm Tocotrienol Preserves Trabecular Osteocyte Indices and Modulates the Expression of Osteocyte Markers in Ovariectomized Rats
by: Sophia Ogechi Ekeuku, et al.
Published: (2025-05-01)